US Stock MarketDetailed Quotes

AKTX Akari Therapeutics

Watchlist
  • 1.3100
  • +0.1000+8.26%
Close Jan 3 16:00 ET
  • 1.3100
  • 0.00000.00%
Post 20:01 ET
34.68MMarket Cap-0.52P/E (TTM)

Akari Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-26.13%1.85M
20.37%5.56M
30.37%5.99M
-27.21%16.81M
5.09M
2.51M
-20.65%4.62M
-12.39%4.59M
34.12%23.09M
34.32%5.82M
Selling and administrative expenses
-39.42%1.71M
-27.50%2.24M
29.58%3.71M
-16.05%11.36M
--2.58M
--2.82M
4.25%3.09M
-7.78%2.86M
67.40%13.53M
38.12%2.97M
-General and administrative expense
-39.42%1.71M
-27.50%2.24M
29.58%3.71M
-16.05%11.36M
--2.58M
--2.82M
4.25%3.09M
-7.78%2.86M
67.40%13.53M
38.12%2.97M
Research and development costs
145.54%143K
117.45%3.31M
31.66%2.28M
-43.00%5.45M
--2.51M
---314K
-46.55%1.52M
-19.10%1.73M
4.68%9.56M
30.58%2.85M
Operating profit
26.13%-1.85M
-20.37%-5.56M
-30.37%-5.99M
27.21%-16.81M
-5.09M
-2.51M
20.65%-4.62M
12.39%-4.59M
-34.12%-23.09M
-34.32%-5.82M
Net non-operating interest income expense
-512.50%-66K
-268.97%-49K
-93.33%2K
78.26%82K
7K
16K
633.25%29K
587.76%30K
333.96%46K
161.06%3.96K
Non-operating interest income
-81.25%3K
-93.10%2K
-93.33%2K
78.26%82K
--7K
--16K
633.25%29K
587.76%30K
333.96%46K
161.06%3.96K
Non-operating interest expense
--69K
--51K
----
----
----
--0
--0
----
----
----
Other net income (expense)
-157.11%-977K
-433.45%-1.95M
-92.43%421K
26.86%6.72M
945K
-380K
343.20%586K
8,701.48%5.57M
2,498.72%5.29M
840.76%132.22K
Gain on sale of security
127.37%98K
-110.02%-60K
-92.41%423K
23.90%6.74M
--918K
---358K
323.55%599K
7,827.55%5.58M
2,913.39%5.44M
1,208.86%141.42K
Special income (charges)
---1.08M
---1.89M
----
----
----
--0
--0
----
----
----
-Less:Restructuring and merger&acquisition
--1.08M
--1.89M
----
----
----
--0
--0
----
----
----
Other non- operating income (expenses)
----
----
81.82%-2K
86.62%-19K
--27K
---22K
-41.23%-13K
-54.73%-11K
-416.70%-142K
-80.67%-9.21K
Income before tax
-0.84%-2.9M
-88.95%-7.56M
-656.04%-5.57M
43.61%-10.01M
-4.14M
-2.87M
29.58%-4M
119.34%1M
-1.86%-17.75M
-30.68%-5.68M
Income tax
Net income
-0.84%-2.9M
-88.95%-7.56M
-656.04%-5.57M
43.61%-10.01M
-4.14M
-2.87M
29.58%-4M
119.34%1M
-1.86%-17.75M
-30.68%-5.68M
Net income continuous Operations
-0.84%-2.9M
-88.95%-7.56M
-656.04%-5.57M
43.61%-10.01M
---4.14M
---2.87M
29.58%-4M
119.34%1M
-1.86%-17.75M
-30.68%-5.68M
Minority interest income
Net income attributable to the parent company
-0.84%-2.9M
-88.95%-7.56M
-656.04%-5.57M
43.61%-10.01M
-4.14M
-2.87M
29.58%-4M
119.34%1M
-1.86%-17.75M
-30.68%-5.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-0.84%-2.9M
-88.95%-7.56M
-656.04%-5.57M
43.61%-10.01M
-4.14M
-2.87M
29.58%-4M
119.34%1M
-1.86%-17.75M
-30.68%-5.68M
Basic earnings per share
58.17%-0.2374
-1.46%-0.8025
-408.94%-0.8275
64.03%-2.0447
-0.8846
-0.5676
58.68%-0.7909
113.86%0.2678
29.98%-5.6853
15.28%-1.9141
Diluted earnings per share
58.17%-0.2374
-1.46%-0.8025
-413.03%-0.8275
64.03%-2.0447
-0.8846
-0.5676
58.68%-0.7909
113.68%0.2643
29.98%-5.6853
15.28%-1.9141
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -26.13%1.85M20.37%5.56M30.37%5.99M-27.21%16.81M5.09M2.51M-20.65%4.62M-12.39%4.59M34.12%23.09M34.32%5.82M
Selling and administrative expenses -39.42%1.71M-27.50%2.24M29.58%3.71M-16.05%11.36M--2.58M--2.82M4.25%3.09M-7.78%2.86M67.40%13.53M38.12%2.97M
-General and administrative expense -39.42%1.71M-27.50%2.24M29.58%3.71M-16.05%11.36M--2.58M--2.82M4.25%3.09M-7.78%2.86M67.40%13.53M38.12%2.97M
Research and development costs 145.54%143K117.45%3.31M31.66%2.28M-43.00%5.45M--2.51M---314K-46.55%1.52M-19.10%1.73M4.68%9.56M30.58%2.85M
Operating profit 26.13%-1.85M-20.37%-5.56M-30.37%-5.99M27.21%-16.81M-5.09M-2.51M20.65%-4.62M12.39%-4.59M-34.12%-23.09M-34.32%-5.82M
Net non-operating interest income expense -512.50%-66K-268.97%-49K-93.33%2K78.26%82K7K16K633.25%29K587.76%30K333.96%46K161.06%3.96K
Non-operating interest income -81.25%3K-93.10%2K-93.33%2K78.26%82K--7K--16K633.25%29K587.76%30K333.96%46K161.06%3.96K
Non-operating interest expense --69K--51K--------------0--0------------
Other net income (expense) -157.11%-977K-433.45%-1.95M-92.43%421K26.86%6.72M945K-380K343.20%586K8,701.48%5.57M2,498.72%5.29M840.76%132.22K
Gain on sale of security 127.37%98K-110.02%-60K-92.41%423K23.90%6.74M--918K---358K323.55%599K7,827.55%5.58M2,913.39%5.44M1,208.86%141.42K
Special income (charges) ---1.08M---1.89M--------------0--0------------
-Less:Restructuring and merger&acquisition --1.08M--1.89M--------------0--0------------
Other non- operating income (expenses) --------81.82%-2K86.62%-19K--27K---22K-41.23%-13K-54.73%-11K-416.70%-142K-80.67%-9.21K
Income before tax -0.84%-2.9M-88.95%-7.56M-656.04%-5.57M43.61%-10.01M-4.14M-2.87M29.58%-4M119.34%1M-1.86%-17.75M-30.68%-5.68M
Income tax
Net income -0.84%-2.9M-88.95%-7.56M-656.04%-5.57M43.61%-10.01M-4.14M-2.87M29.58%-4M119.34%1M-1.86%-17.75M-30.68%-5.68M
Net income continuous Operations -0.84%-2.9M-88.95%-7.56M-656.04%-5.57M43.61%-10.01M---4.14M---2.87M29.58%-4M119.34%1M-1.86%-17.75M-30.68%-5.68M
Minority interest income
Net income attributable to the parent company -0.84%-2.9M-88.95%-7.56M-656.04%-5.57M43.61%-10.01M-4.14M-2.87M29.58%-4M119.34%1M-1.86%-17.75M-30.68%-5.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -0.84%-2.9M-88.95%-7.56M-656.04%-5.57M43.61%-10.01M-4.14M-2.87M29.58%-4M119.34%1M-1.86%-17.75M-30.68%-5.68M
Basic earnings per share 58.17%-0.2374-1.46%-0.8025-408.94%-0.827564.03%-2.0447-0.8846-0.567658.68%-0.7909113.86%0.267829.98%-5.685315.28%-1.9141
Diluted earnings per share 58.17%-0.2374-1.46%-0.8025-413.03%-0.827564.03%-2.0447-0.8846-0.567658.68%-0.7909113.68%0.264329.98%-5.685315.28%-1.9141
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data